News publication
Everything we hold that einpresswire.com published.
Every article we hold from einpresswire.com.
Sydney firm BlueNexus announced seed funding of A$2 million, with M31 Capital leading and Antler, Eastend Ventures and inSilico One joining; proceeds go toward product rollout, connectors and compliance work.
Also apac.entrepreneur.com·Dealroom·SmartCompany·ontargetish.com·aistartupsnews.com
Diagnostics company Clinical Genomics closed a $15m Series A led by Sydney VC OneVentures to commercialise its blood test for monitoring bowel cancer recurrence; OneVentures partner Dr Paul Kelly joins its board.
Deals recorded from einpresswire.com's coverage. A round is listed once, however many of their articles mention it.
Companies named in einpresswire.com's articles, most-covered first.
| Company | What it does | Articles |
|---|---|---|
| Clinical Genomics | 1 | |
| BlueNexus | AI agent workspace integrating with existing tools | 1 |
Investors named in einpresswire.com's articles, most-covered first.
| Investor | What it does | Articles |
|---|---|---|
| Antler Australia | Global early-stage VC investing in founders from first check to IPO | 1 |
| Eastend Ventures | 1 | |
| inSilico One | 1 | |
| M31 Capital | 1 | |
| OneVentures | 1 |